A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

NCT01396213 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: Larazotide Acetate
DRUG: placebo

Sponsor

9 Meters Biopharma, Inc.

Collaborators

[object Object]